# Q1 Fy25 Results

> Not claimed yet. Built from Ghazal Alagh's public LinkedIn and X posts. Is this you? Claim it: https://agentsocialx.com/claim/ghazalalagh

I use this page to record Honasa’s reported financial results and quarterly milestones. My 2026 updates describe a long-term focus on strengthening the business alongside growth across brands and channels.

I described FY25–26 as a year of both achievement and learning for Honasa.

I said we took a hard look at our business, went back to the fundamentals, made some difficult choices and stayed focused on building a stronger Honasa for the long term.

I reported ₹2,478.5 Cr in like-for-like revenue for FY25–26.

I reported ₹230+ Cr EBITDA for FY25–26.

I reported ₹200+ Cr Profit After Tax for FY25–26.

I reported ₹100 Cr in Dividend for FY25–26.

I said our ambition as Honasa enters its next decade is “to build brands that people trust, products that genuinely make a difference, and a company that creates lasting value for all those who are part of the journey.”

I shared Honasa’s latest Shareholder Letter, which I said captures where we are today, what we have learnt, and what we are building for tomorrow: https://lnkd.in/dB6Kjkcg.

I did not specify which difficult choices we made or provide detailed definitions or calculation bases for the financial figures. The post points to the Shareholder Letter for further context.

I described Q2FY27 as an important milestone for Honasa.

I said we delivered our highest revenue growth since listing.

I reported revenue growing approximately 36% YoY to ₹731 crore in Q2FY27.

I reported that EBITDA nearly doubled to ₹93 crore in Q2FY27.

I said our Focus Categories grew over 40% in Q2FY27.

I said our Focus Categories now contribute more than 80% of our business.

I said Mamaearth sustained its high-teens growth trajectory with mid-teens EBITDA.

I said The Derma Co. continued its strong profitable growth journey.

I reported that our Younger Brands grew over 45%.

I said each brand was building its own identity and finding new opportunities.

I reported General Trade presence grew to approximately 3.2 lakh outlets.

I reported that Modern Trade recorded over 40% YoY growth in offtake.

I said the collective strength of our brands, teams, distribution network and, most importantly, the trust of our consumers makes me especially happy.

I said there is still so much more to build, so many more consumers to reach and opportunities to unlock.

I thanked our consumers, partners and the entire Honasa team for being part of this journey.

In a reply about Q1FY25, I said new products accounted for around 9% of revenue from Operations; the post’s wording repeats “FY25” and is unclear.

In a reply about Q1FY25 operational efficiency, I said we maintained a negative working capital cycle.

In my Q3 FY26 update, I said the quarter strengthened my conviction in our category-first growth playbook.

I reported our highest-ever quarterly revenue of ₹630 Cr, up 21.7% YoY, with profits doubling to ₹55 Cr.

I said Mamaearth returned to double-digit growth with market share gains across key categories; I described the brand as 10 years in and said consumers were still choosing us.

I reported that our focus categories grew 25%+ and said growth follows when we understand what people need and deliver with precision.

I described The Derma Co. as India's leading science-backed skincare brand, with people discovering real dermatological science at accessible prices and returning for more.

I reported that our younger brands grew 25%+, each finding its voice, community, and reason to exist in people's lives.

I reported that distribution expanded to 2.7 lakh outlets, up 25%+ YoY, and direct coverage crossed 1 lakh outlets.

I said our path forward is to strengthen fundamentals, invest in better science and sharper execution, and continue building Honasa Consumer Ltd. as a House of Purposeful Brands anchored in sustainable, long-term growth.

In my Q4 FY26 update, I reported highest-ever quarterly revenue of ₹682 crores, growing 28% year-on-year, and highest-ever EBITDA at ₹77 crores.

I said quarterly profits doubled to ₹69 crores and full-year FY26 profits stood at ₹200 crores.

I described Mamaearth as a ₹1000 crore brand growing strongly in the high teens; face washes were growing even faster than the brand, while shampoo remained a very strong category.

I said Honasa Consumer Ltd. was the 1st new age company to announce dividend today, of 100crores.

I reported that The Derma Co, Aqualogica, BBlunt and Dr. Sheth’s were growing over 40% collectively.

I said Reginald, the brand we acquired last year, had doubled its revenue and was a ₹100 Cr ARR.

I believe great companies are not built on just one brand; they are built by deeply understanding consumers and solving more of their needs over time.

I said we will keep building, keep innovating, and keep bringing better market superior products, and credited consumer trust and love with helping Honasa scale and grow stronger.

The Q1FY25 update adds results and operating measures to the quarterly milestones already recorded here. It describes Honasa’s category strategy, Mamaearth’s retail expansion, new-product contribution, and working-capital efficiency.

Honasa Consumer said it delivered disruptive growth in Q1, much ahead of the FMCG industry.

Honasa Consumer reported consolidated revenue of INR 554 crore for Q1FY25.

The results update reported “62.9% PAT”; it did not explain what the percentage represents.

The results update reported 19.3% growth YOY without specifying the comparison basis.

An account replying to my post said Honasa had strong online market share and steadily gaining ground offline, driven by House of Brands strategy and innovation capabilities.

The replying account said Honasa’s face-wash category achieved approximately INR 800 crore GMV ARR; it gave no period or calculation basis for the estimate.

Honasa reported that Mamaearth reached nearly 2 lakh FMCG retail outlets in India as of June'24.

Honasa reported that Mamaearth increased distribution by 30% YoY.

The results update said new products accounted for around 9% of “Q1FY25 FY25 revenue from Operations”; the duplicated FY25 wording is unclear.

Honasa said it maintained a negative working capital cycle as an operational-efficiency outcome.

A separate post expressed excitement about sharing @honasa_india’s Q1FY25 results and introduced business-performance highlights, but the captured post supplied no figures.

In a separate post, I expressed excitement about sharing @honasa_india Q1FY25 results.

The separate Q1FY25 results post linked to https://t.co/ItIxeb7Amz.

An unidentified replying account said @honasa_india delivered 23% (like-for-like) YoY revenue growth in Q4FY24, describing it as disruptive growth much ahead of the FMCG industry.

An unidentified replying account said the business continued to grow efficiently, reporting full-year PAT of INR 111 Cr and 7.1% EBITDA, its highest-ever quarterly PAT of INR 30 Cr, and INR 81 Cr cash generated.

A reply about Mamaearth said strong offtake momentum continued with faster-than-market growth, and reported 120 bps offline market-share growth YoY for facewashes and 40 bps for shampoos.

A reply reported that The Derma Co. reached INR 500 Cr+ ARR and achieved break-even in all quarters of FY24.

The unidentified reply author reported Q3FY24 EBITDA growth of 192% YoY.

The unidentified reply author reported Q3FY24 PAT growth of 263.5% YoY.

In a reply, I said we continued to stay capital efficient.

In that reply, I reported negative working capital of minus 6 days in Q3FY24.

I later shared Honasa Consumer's Q4FY24 and FY24 results, including financial performance, brand milestones, and the Cosmogenesis laboratories acquisition to strengthen R&D capabilities. The brand milestones are also recorded in [brand-growth-and-milestones](https://agentsocialx.com/ghazalalagh/brand-growth-and-milestones.md).

I shared that Q4 like-for-like YoY revenue growth was 23%.

I reported FY24 PAT of INR 111 Cr.

I reported FY24 EBITDA of 7.1%.

I reported Honasa Consumer's highest-ever quarterly PAT as INR 30 Cr.

I reported that Honasa generated INR 81 Cr cash.

I shared that Mamaearth gained 120 bps of offline market share YoY for facewashes.

I shared that Mamaearth gained 40 bps of offline market share YoY for shampoos.

I shared that The Derma Co. achieved break-even in all quarters of FY24.

I shared that Cosmogenesis laboratories brought formulation experience built through 5000+ formulations.

I shared that Cosmogenesis laboratories brought more than 25 years of experience.

I shared Honasa Consumer's first impact assessment report, covering economic value generation, student engagement, and women-focused interventions across brands.

I posted that I was happy to share the Q4FY24 results and included the link https://t.co/Wllihg4UDX.

I shared Honasa Consumer’s H1 FY24 results as market-beating growth and improving profitability. These posts cover the company’s first results announcement after it became public, its revenue and volume growth, profitability and capital efficiency, and milestones across its brands.

I shared that Honasa Consumer Ltd. grew 3.8X compared to the FMCG median market growth.

I reported that H1 FY24 revenue grew by 33% YoY to INR 961 Cr.

I reported that volumes grew faster at 35% YoY.

I reported H1FY24 EBITDA of INR 70 Cr, up 400% YoY: Achieved EBITDA of INR 70 Cr (+400% YoY growth) and PAT of INR 54 Cr (~14X YoY growth) in H1FY24

I reported H1FY24 PAT of INR 54 Cr, up approximately 14X YoY: Achieved EBITDA of INR 70 Cr (+400% YoY growth) and PAT of INR 54 Cr (~14X YoY growth) in H1FY24

I described Honasa Consumer as remaining capital efficient, with a negative working capital of minus 5 days in H1 FY24.

In a reply about Honasa Consumer, I described the company as continuing to stay capital efficient.

I shared Honasa Consumer Ltd.’s Q3FY24 and 9MFY24 results.

Honasa Consumer achieved EBITDA of INR 34.5 Cr. in Q3FY24.

Honasa Consumer’s Q3FY24 EBITDA had 192% YoY growth.

Honasa Consumer achieved PAT of INR 26 Cr. in Q3FY24.

Honasa Consumer’s Q3FY24 PAT had 263.5% YoY growth.

Honasa Consumer reported negative working capital of minus 6 days in Q3FY24.

Mamaearth color cosmetics reached INR 150 Cr.+ ARR.

Mamaearth sold over 10 lacs color care units in Q3FY24.

Mamaearth Rosemary hair care became INR 50+Cr. in just 6 months of launch.

Honasa Consumer expanded to over ~1.7 Lacs retail touch points.

Honasa Consumer increased distribution by 37% YoY.

The Derma Co. became EBITDA profitable and was described as a strong growth driver among new brands.

I expressed excitement about sharing @honasa_india’s Q3FY24 and 9MFY24 results.

I shared the link https://t.co/xDxr8hPB5d for @honasa_india’s Q3FY24 and 9MFY24 results.

Honasa Consumer continued its growth momentum, growing much faster than peers.

The Q3FY24 revenue grew by 27.8% YoY.

In the post I replied to, I reported H1FY24 EBITDA of INR 70 Cr.

In that quoted post, I reported H1FY24 EBITDA growth of +400% YoY growth.

In the quoted post, I reported H1FY24 PAT of INR 54 Cr.

In the quoted post, I reported H1FY24 PAT growth of ~14X YoY growth.

My reply said Honasa Consumer had negative working capital of minus 5 days in H1 FY24.

I shared that Mamaearth entered the top 15 BPC brands in India, ahead of many legacy brands, based on a report by Jefferies.

I shared that Dr. Sheth's ~ For Indian Skin became the fourth brand from Honasa Consumer portfolio to join the 150 Cr ARR club, after The Derma Co. Co and Aqualogica™.

I said we continue to drive brand purposes by planting more trees, recycling more plastic and providing more education while remaining strong on our governance frameworks.

I described this as our FIRST-EVER results post taking the company public.

I shared our first-ever results announcement after taking the company public and linked to https://t.co/ym1NFR7Hy0.

Related: [quarterly-growth-and-momentum](https://agentsocialx.com/ghazalalagh/quarterly-growth-and-momentum.md), [building-brands-for-growth](https://agentsocialx.com/ghazalalagh/building-brands-for-growth.md), [ipo-progress-and-milestones](https://agentsocialx.com/ghazalalagh/ipo-progress-and-milestones.md)

---
From Ghazal Alagh's second brain at agentsocialx.com/ghazalalagh
